What are the most valued startups in the alternative protein market?

Last updated: 13 July 2026

Download our beautiful pitch about the alternative protein market

market research pitch 2026 statistics alternative protein market

In our alternative protein market deck, you will find everything you need to understand the market

The alternative protein market includes plant-based foods, precision-fermented ingredients, mycoprotein products, and cultivated meat and seafood.

This ranking tracks the most valuable alternative protein startups using reported valuations, public market capitalizations, acquisition values, and structured estimates.

We update this list every month to reflect new funding rounds, market movements, acquisitions, shutdowns, and other material developments.

And if you want to better understand this new industry, you can download our pitch covering the alternative protein market.

A quick summary table

Metric Value
Most valuable alternative protein startup Perfect Day, estimated at $1.3B–$1.7B
Second most valuable alternative protein startup NotCo, estimated at $1.3B–$1.6B
Median alternative protein startup valuation Approximately $85M
Share of alternative protein valuation captured by the top 10 Approximately 51%
Top alternative protein valuation vs. median Approximately 17.6 times
Median alternative protein valuation-to-capital-raised ratio Approximately 2.3 times
Alternative protein startups valued at $1B+ 5 startups
Market map chart showing top companies and startups in the alternative protein market

This market map, featured in our alternative protein market deck, highlights top companies and startups in the alternative protein market

Top startups in the alternative protein market ranked by valuation

Here is an updated table that ranks the top startups in the alternative protein market based on their latest reported or estimated valuations.

If you want more detaild about their fundraising activity, you can check our list of the startups who have raised the most funding in the alternative protein market.

# Startup Name What They Do Current Valuation ($) Valuation Confidence Level Valuation Type Evidence Status Total Funding ($) Funding Confidence Level
1 Perfect Day Animal-free dairy proteins $1.3B–$1.7B Strong Confidence Comparables-Based Estimate Estimated $750M Partial Confidence
2 NotCo AI-designed plant-based foods $1.3B–$1.6B Partial Confidence Announced Private Round Valuation Estimated $500M Partial Confidence
3 LIVEKINDLY Collective Plant-based brand platform $900M–$1.3B Partial Confidence Comparables-Based Estimate Estimated $535M Strong Confidence
4 Eat Just Plant eggs and cultivated meat $800M–$1.3B Low Confidence Proxy-Based Estimate Estimated $1.5B Strong Confidence
5 Ripple Foods Pea-protein dairy alternatives $800M–$1.2B Partial Confidence Revenue or ARR Multiple Estimate Estimated $300M Partial Confidence
6 Califia Farms Plant-based beverages $700M–$1.1B Partial Confidence Revenue or ARR Multiple Estimate Estimated $600M Partial Confidence
7 Nature’s Fynd Fungi-derived protein foods $450M–$700M Partial Confidence Comparables-Based Estimate Estimated $463M Full Confidence
8 NxtFood ACCRO plant-based meats $390M–$620M Partial Confidence Implied Valuation from Raise Implied $76M Partial Confidence
9 Impossible Foods Plant-based meat products $400M–$550M Partial Confidence Proxy-Based Estimate Estimated $2.2B Strong Confidence
10 Remilk Fermented animal-free dairy proteins $400M–$550M Strong Confidence Announced Private Round Valuation Implied $131M Full Confidence
11 The EVERY Company Animal-free egg proteins $350M–$500M Strong Confidence Implied Valuation from Raise Implied $287M Strong Confidence
12 Wildtype Cultivated salmon seafood $350M–$500M Strong Confidence Comparables-Based Estimate Estimated $123M Strong Confidence
13 Infinite Roots Mycelium fermentation protein $300M–$450M Partial Confidence Implied Valuation from Raise Estimated $70M Strong Confidence
14 Nobell Foods Plant-grown dairy proteins $280M–$420M Partial Confidence Comparables-Based Estimate Estimated $102M Partial Confidence
15 ENOUGH Mycoprotein ingredient production $240M–$380M Partial Confidence Comparables-Based Estimate Estimated $104M Strong Confidence
16 Beyond Meat Plant-based meat products $309M Full Confidence Public Market Cap Observed $1.4B Strong Confidence
17 Oatly Oat milk dairy alternative $301M Full Confidence Public Market Cap Observed $1.7B Strong Confidence
18 Redefine Meat 3D-printed plant-based meat $220M–$380M Partial Confidence Announced Private Round Valuation Estimated $170M Strong Confidence
19 Formo Fermented animal-free cheese $260M–$340M Strong Confidence Implied Valuation from Raise Implied $115M Strong Confidence
20 Onego Bio Fermented egg-white protein $220M–$320M Partial Confidence Implied Valuation from Raise Implied $66M Partial Confidence
21 No Meat Factory Plant protein manufacturing $180M–$320M Partial Confidence Implied Valuation from Raise Implied $60M Partial Confidence
22 Planted Foods Clean-label plant meats $180M–$300M Partial Confidence Comparables-Based Estimate Estimated $117M Strong Confidence
23 The Protein Brewery Fungi protein ingredients $190M–$280M Strong Confidence Implied Valuation from Raise Implied $85M Strong Confidence
24 Vow Novel cultivated meat products $180M–$280M Strong Confidence Revenue or ARR Multiple Estimate Estimated $55M Full Confidence
25 Standing Ovation Animal-free casein proteins $180M–$270M Strong Confidence Implied Valuation from Raise Implied $45M Strong Confidence
26 Revyve Yeast-based egg replacements $175M–$260M Strong Confidence Implied Valuation from Raise Implied $47M Strong Confidence
27 Vivici Fermented dairy proteins $170M–$260M Strong Confidence Implied Valuation from Raise Implied $34M Partial Confidence
28 Prime Roots Koji deli meats $150M–$250M Partial Confidence Implied Valuation from Raise Implied $49M Strong Confidence
29 Heura Foods Mediterranean plant-based meats $130M–$220M Partial Confidence Revenue or ARR Multiple Estimate Estimated $85M Partial Confidence
30 Future Farm Plant-based meat products $120M–$220M Partial Confidence Announced Private Round Valuation Estimated $89M Strong Confidence
31 Eclipse Foods Plant-based dairy products $120M–$220M Partial Confidence Implied Valuation from Raise Implied $56M Partial Confidence
32 MyForest Foods Mycelium meat alternatives $120M–$200M Partial Confidence Comparables-Based Estimate Estimated $55M Partial Confidence
33 Mission Barns Cultivated pork fat $120M–$180M Partial Confidence Comparables-Based Estimate Estimated $28M Strong Confidence
34 Gourmey / PARIMA Cultivated poultry and foie gras $120M–$180M Partial Confidence Comparables-Based Estimate Estimated $58M Strong Confidence
35 v2food Australian plant-based meats $100M–$180M Low Confidence Comparables-Based Estimate Estimated $137M Strong Confidence
36 Imagindairy Fermented animal-free milk proteins $100M–$160M Partial Confidence Comparables-Based Estimate Estimated $28M Strong Confidence
37 Novameat Plant-based whole cuts $90M–$160M Partial Confidence Implied Valuation from Raise Implied $26M Strong Confidence
38 Konscious Foods Plant-based frozen seafood $100M–$145M Partial Confidence Implied Valuation from Raise Implied $26M Strong Confidence
39 Eden Brew Animal-free dairy proteins $90M–$150M Partial Confidence Comparables-Based Estimate Estimated $23M Partial Confidence
40 Kite Hill Almond dairy alternatives $80M–$150M Low Confidence Proxy-Based Estimate Estimated $250M Partial Confidence
41 Better Dairy Fermented dairy proteins $70M–$120M Partial Confidence Implied Valuation from Raise Estimated $24M Full Confidence
42 Those Vegan Cowboys Fermented animal-free dairy proteins $75M–$105M Partial Confidence Implied Valuation from Raise Implied $14M Strong Confidence
43 BLUU Seafood Cultivated fish products $70M–$105M Partial Confidence Implied Valuation from Raise Implied $26M Full Confidence
44 THIS UK plant-based meat brand $75M–$95M Partial Confidence Announced Private Round Valuation Implied $70M Strong Confidence
45 MALK Organics Organic plant-based milks $65M–$95M Partial Confidence Comparables-Based Estimate Estimated $24M Partial Confidence
46 Ivy Farm Technologies Cultivated beef production $60M–$100M Partial Confidence Comparables-Based Estimate Estimated $43M Partial Confidence
47 Bon Vivant Animal-free dairy proteins $55M–$95M Partial Confidence Implied Valuation from Raise Estimated $20M Strong Confidence
48 Armored Fresh Plant-based cheese products $55M–$90M Low Confidence Comparables-Based Estimate Estimated $33M Partial Confidence
49 Plonts Fermented plant-based cheese $50M–$80M Partial Confidence Implied Valuation from Raise Estimated $12M Full Confidence
50 CellMEAT Cultivated seafood products $50M–$80M Partial Confidence Implied Valuation from Raise Implied $26M Strong Confidence
51 Tender Food / Lasso Fiber-spun plant proteins $45M–$80M Partial Confidence Implied Valuation from Raise Implied $32M Strong Confidence
52 Change Foods Fermented dairy proteins $45M–$75M Low Confidence Comparables-Based Estimate Estimated $15M Partial Confidence
53 Chunk Foods Fermented whole-cut meat $40M–$75M Partial Confidence Implied Valuation from Raise Implied $25M Full Confidence
54 CellX Cultivated meat products $40M–$70M Low Confidence Comparables-Based Estimate Estimated $26M Partial Confidence
55 Alpha Foods Plant-based frozen meals $35M–$70M Low Confidence Acquisition Value Estimated $35M Full Confidence
56 Ever After Foods Cultivated-meat bioreactor technology $40M–$65M Partial Confidence Implied Valuation from Raise Implied $10M Partial Confidence
57 Black Sheep Foods Plant-based lamb protein $35M–$65M Partial Confidence Implied Valuation from Raise Implied $18M Strong Confidence
58 Fork & Good Cultivated pork $40M–$60M Partial Confidence Comparables-Based Estimate Estimated $22M Strong Confidence
59 Bettani Farms / Climax Foods Dairy-free cheese technology $35M–$55M Strong Confidence Implied Valuation from Raise Implied $14M Full Confidence
60 SuperMeat Cultivated chicken meat $35M–$50M Strong Confidence Active Raise Valuation Implied $24M Partial Confidence
61 Daring Foods Plant-based chicken products $20M–$60M Low Confidence Proxy-Based Estimate Estimated $130M Partial Confidence
62 Umami Bioworks Cultivated seafood production platform $30M–$50M Partial Confidence Comparables-Based Estimate Estimated $2M Full Confidence
63 Multus Biotechnology Animal-free cell growth media $30M–$45M Partial Confidence Comparables-Based Estimate Estimated $9M Strong Confidence
64 IntegriCulture Cellular agriculture production platform $30M–$40M Partial Confidence Proxy-Based Estimate Estimated $17M Strong Confidence
65 New Culture Animal-free casein cheese $28M–$38M Partial Confidence Comparables-Based Estimate Estimated $29M Strong Confidence
66 Rebellyous Foods Plant-based chicken manufacturing $20M–$35M Low Confidence Proxy-Based Estimate Estimated $30M Partial Confidence
67 Avant Meats Cultivated fish and seafood $20M–$35M Low Confidence Comparables-Based Estimate Estimated $14M Strong Confidence
68 Forsea Foods Organoid-grown cultivated eel $18M–$30M Low Confidence Comparables-Based Estimate Estimated $5M Full Confidence
69 Current Foods Plant-based tuna and salmon $15M–$30M Low Confidence Acquisition Value Estimated $24M Partial Confidence
70 Orbillion Bio Cultivated heritage meats $15M–$30M Low Confidence Acquisition Value Estimated $15M Partial Confidence
71 Juicy Marbles Plant-based whole-cut steaks $12M–$25M Low Confidence Comparables-Based Estimate Estimated $5M Strong Confidence
72 Mirai Foods Non-GMO cultivated beef $12M–$22M Low Confidence Proxy-Based Estimate Estimated $5M Full Confidence
73 Shiok Meats Cultivated shrimp and crustaceans $10M–$20M Low Confidence Acquisition Value Estimated $31M Partial Confidence
74 Uncommon Cultivated pork technology $8M–$18M Low Confidence Acquisition Value Estimated $35M Strong Confidence
75 Miyoko’s Creamery Vegan cheese and butter $5M–$15M Low Confidence Acquisition Value Estimated $90M Partial Confidence
76 Barvecue Plant-based smoked barbecue $7M–$13M Low Confidence Implied Valuation from Raise Implied $3M Partial Confidence
77 Steakholder Foods Printed alternative-protein systems $9M Full Confidence Public Market Cap Observed $54M Partial Confidence
78 Mycorena Mycoprotein ingredient platform $3M–$10M Low Confidence Acquisition Value Estimated $38M Partial Confidence
79 Spero Foods Plant-based dairy and eggs $3M–$8M Low Confidence Proxy-Based Estimate Estimated $8M Partial Confidence
80 Finless Foods Cultivated bluefin tuna $5M Strong Confidence Active Raise Valuation Observed $48M Partial Confidence
81 Daisy Lab Animal-free dairy proteins $3M–$6M Partial Confidence Proxy-Based Estimate Estimated $1M Strong Confidence
82 Meati Mycelium meat alternatives $4M Strong Confidence Acquisition Value Observed $333M Partial Confidence>
83 Motif FoodWorks Alternative-protein food ingredients $0M–$5M Low Confidence Proxy-Based Estimate Estimated $344M Strong Confidence
84 Stockeld Dreamery Cultured plant-based cheese $1M–$4M Low Confidence Acquisition Value Estimated $24M Full Confidence
85 SCiFi Foods Hybrid cultivated beef $1M–$3M Low Confidence Acquisition Value Estimated $29M Strong Confidence
86 Aqua Cultured Foods Fermented seafood alternatives $0M–$2M Strong Confidence Proxy-Based Estimate Estimated $8M Strong Confidence
87 New Wave Foods Plant-based shrimp $0M–$1M Strong Confidence Proxy-Based Estimate Estimated $20M Partial Confidence
Chart comparing the 2026 size of the alternative protein market with other markets of similar size

This chart, featured in our alternative protein market deck, compares the 2026 size of the alternative protein market with other markets of similar size

Key valuation trends in the alternative protein market

Insights

  • Oatly and Beyond Meat raised approximately $3.1B combined, but their aggregate public-market value is only about $610M, or roughly 20% of the capital invested in the two plant-based brands.
  • Fermentation-focused companies Remilk, Formo, The Protein Brewery, Standing Ovation, and Revyve have a combined valuation midpoint near $1.5B against approximately $423M raised, showing stronger capital leverage than many consumer brands.
  • Wildtype has an estimated valuation midpoint of $425M, approximately 3.5 times its $123M funding, making Wildtype one of the strongest valuation-to-capital outcomes among commercially advancing cultivated-protein startups.
  • Vow’s estimated $230M valuation midpoint is more than four times its $55M funding, suggesting that regulatory approvals and early market access can materially increase cultivated meat startup valuations.
  • Standing Ovation and Revyve raised approximately $92M combined but have a combined valuation midpoint near $443M, highlighting investor demand for scalable alternative protein ingredients sold to other food manufacturers.
  • The alternative protein market remains concentrated, with the ten most valuable companies accounting for approximately 51% of the combined valuation represented in this ranking.
Chart showing Impossible Foods’ strategy in the alternative protein market

This chart, featured in our alternative protein market deck, looks at Impossible Foods’ strategy in alternative protein

A few word about our methodology

As you can see, we built a database that ranks startups in the alternative protein market based on their current valuation.

Estimating alternative protein startup valuations is not always straightforward. Many companies do not publicly disclose their valuation, and the available information can vary widely depending on the company, technology, and development stage.

To build this ranking, we applied a structured valuation methodology and cross-checked information across multiple reliable sources.

Whenever possible, we relied on direct disclosures. These include announced valuations from completed funding rounds, public filings for listed alternative protein companies, or official acquisition prices.

When an alternative protein company is publicly listed, we use its current market capitalization as the reference valuation.

If an alternative protein startup was acquired and no independent valuation can reasonably be estimated today, we use the acquisition price as the main reference point.

When a startup recently raised capital but the valuation was not disclosed, we estimate the implied valuation using typical dilution levels for that stage of fundraising.

In some cases, we also estimate valuations using operating metrics such as revenue, ARR, production capacity, commercial partnerships, or customer traction, combined with valuation multiples from comparable alternative protein companies.

When direct financial data is not available, we may rely on carefully selected comparable startups and other signals such as regulatory approvals, manufacturing progress, hiring growth, investor quality, product launches, or commercial traction.

All estimates follow a strict evidence hierarchy. Recent funding rounds with announced valuations carry the most weight, followed by strong operating metrics and comparable company analysis.

We also carefully evaluate the age of every data point. Recent information carries more weight, while older data is treated cautiously and adjusted conservatively when necessary.

Whenever information is uncertain or incomplete, we clearly distinguish between confirmed facts and reasonable inferences.

Because valuation data is not always fully public, each alternative protein startup in the ranking is assigned a confidence level based on the reliability, recency, and consistency of the available evidence.

Full confidence means the valuation is supported by strong and recent evidence. Strong confidence means the estimate is well supported but includes minor inference. Partial confidence means the estimate relies more heavily on indirect signals. Low confidence means available information is limited or inconsistent.

When confidence is lower, we take a more conservative approach by widening the valuation range. This helps reflect the uncertainty and increases the probability that the true valuation falls within the estimated range.

This reflects how we conduct all our research, including the work behind our report covering the alternative protein market.

In a world where LLMs hallucinate and unreliable information is everywhere, our goal is simple: provide data you can trust.

If you want the full detail on a specific valuation estimate, feel free to contact us and we will gladly explain.

Finally, know that we update the dataset once per month, so come back here if you need fresh information.

Chart showing the projected CAGR of the alternative protein market

This chart, featured in our alternative protein market deck, shows annual funding in alternative protein startups

Related blog posts

- What is the latest news in the alternative protein market?

- The latest funding news in the alternative protein market

- What is new in the alternative protein market?

- How funding activity has evolved in the alternative protein market

- What are the key fundraising trends in the alternative protein market?

- What is the actual size of the alternative protein market?

- A complete list of business models in the alternative protein market

Who is the author of this content?

NEW MARKET PITCH TEAM

We track new markets so founders and investors can move faster

We build living “market pitch” documents for emerging markets: from AI to synthetic biology and new proteins. Instead of digging through outdated PDFs, random blog posts, and hallucinated LLM answers, our clients get a clean, visual, always-updated view of what’s really happening. We map the key players, deals, regulations, metrics and signals that matter so you can decide faster whether a market is worth your time. Want to know more? Check out our about page. You can also follow us on Instagram or on Facebook.

How we created this content 🔎📝

At New Market Pitch, we kept seeing the same problem: when you look at a new market, the data is either missing, paywalled, or buried in 300-page reports that feel like they were written in the 80s. On the other side, LLMs and random blog posts give you confident answers with no sources, and sometimes they just make things up. That’s not good enough when you’re about to invest real money or launch a company.

So we decided to fix the experience. For each market we cover, we build a structured database and update it on a regular basis. We track funding rounds, fund memos, M&A moves, partnerships, new products, policy changes, and the real activity of startups and incumbents. Then we turn all of that into a clear “market pitch” that shows where the opportunities are and how people actually win in that space.

Every key data point is checked, sourced, and put back into context by our team. That’s how we can give you both speed and reliability: fast coverage of new markets, without the usual guesswork.

Back to blog